Marked increase in cyclooxygenase-2 in ALS spinal cord: Implications for therapy

Neurology

Volumn 57, Issue 6, 2001, Pages 952-956

  Yasojima, K ^a   Tourtellotte, W W ^b   McGeer, E G ^a   McGeer, Patrick L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; NEUROPROTECTIVE AGENT;

AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INFLAMMATION; MICROGLIA; MOTOR NEURON DISEASE; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD;

EID: 0035949799     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.6.952     Document Type: Article

References (22)

1. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue
2. Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis
3. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease
4. Immunohistochemical characteristics of the inflammatory infiltration in amyotrophic lateral sclerosis
5. Prostaglandin endoperoxide H synthases (cyclooxygenases) -1 and -2
6. Cyclooxygenase-2: Molecular biology, pharmacology and neurobiology
7. Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis
8. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis
9. Brain microglia constitutively express β-2 integrins
10. Human heart generates complement proteins that are upregulated and activated after myocardial infarction
11. Upregulated production and activation of the complement system in Alzheimer's disease brain
12. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs
13. Reduced neprilysin in high plaque areas of Alzheimer brain: A possible relationship to deficient degradation of β-amyloid peptide
14. PK 11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalitis
15. Interleukin-1 betamediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity
16. Functional roles of caspase-1 and caspase-2 in an ALS transgenic mouse model
17. Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans
18. Increased levels of cyclooxygenase-2 mRNA in the rat spinal cord after peripheral inflammation: An in situ hybridization study
19. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS
20. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage
21. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia
22. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate neurotoxicity in cyclooxygenase-2-deficient mice